Table of Content


1 INTRODUCTION 
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 INCLUSIONS AND EXCLUSIONS 
    1.4 MARKET SCOPE 
           1.4.1 MARKET SEGMENTATION
           1.4.2 REGIONAL SCOPE
    1.5 YEARS CONSIDERED 
    1.6 CURRENCY CONSIDERED 
    1.7 STAKEHOLDERS 
    1.8 RECESSION IMPACT 
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH DATA 
    2.2 SECONDARY DATA 
           2.2.1 KEY DATA FROM SECONDARY SOURCES
    2.3 PRIMARY DATA 
           2.3.1 KEY DATA FROM PRIMARY SOURCES
           2.3.2 KEY INDUSTRY INSIGHTS
           2.3.3 BREAKDOWN OF PRIMARY INTERVIEWS
    2.4 MARKET SIZE ESTIMATION 
    2.5 MARKET SHARE ANALYSIS 
    2.6 MARKET BREAKDOWN AND DATA TRIANGULATION 
           2.6.1 DIGITAL HEALTH MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS
    2.7 RESEARCH ASSUMPTIONS 
    2.8 RISK ASSESSMENT 
    2.9 LIMITATIONS 
    2.1 IMPACT OF RECESSION ON DIGITAL HEALTH MARKET 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
    4.1 DIGITAL HEALTH MARKET: MARKET OVERVIEW 
    4.2 DIGITAL HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
    4.3 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COMPONENT AND END USER 
    4.4 REGIONAL MIX: DIGITAL HEALTH MARKET (2021–2028) 
5 MARKET OVERVIEW 
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 INDUSTRY TRENDS 
    5.4 TECHNOLOGY ANALYSIS 
    5.5 ECOSYSTEM ANALYSIS 
    5.6 VALUE CHAIN ANALYSIS 
    5.7 PORTER’S FIVE FORCES ANALYSIS 
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    5.8 PATENT ANALYSIS 
           5.8.1 PATENT PUBLICATION TRENDS FOR DIGITAL HEALTH
           5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    5.9 TARIFF & REGULATORY LANDSCAPE 
           5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
           5.9.2 NORTH AMERICA
                    5.9.2.1 US
                    5.9.2.2 Canada
           5.9.3 EUROPE
           5.9.4 ASIA PACIFIC
                    5.9.4.1 India
                    5.9.4.2 Japan
                    5.9.4.3 China
    5.10 PRICING ANALYSIS 
           5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
    5.11 TRENDS & DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESS 
           5.11.1 REVENUE SHIFT & NEW REVENUE POCKETS FOR DIGITAL HEALTH MARKET
    5.12 KEY CONFERENCES & EVENTS IN 2023–2024 
    5.13 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.13.2 BUYING CRITERIA
    5.14 UNMET NEEDS – DIGITAL HEALTH MARKET 
    5.15 CASE STUDY ANALYSIS 
    5.16 ADJACENT MARKET ANALYSIS 
6 DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 
    6.1 INTRODUCTION 
    6.2 HARDWARE 
    6.3 SOFTWARE  
           6.3.1 ANNUAL LICENSING
           6.3.2 SUBSCRIPTION-BASED
    6.4 SERVICES 
           6.4.1 SUBSCRIPTION-BASED
           6.4.2 PAY-PER SERVICE (VALUE-BASED)
    6.5 APPLICATIONS (ONLY PAID APPLICATIONS) 
           6.5.1 ONE TIME PURCHASE
           6.5.2 SUBSCRIPTION-BASED
           6.5.3 PAY-PER USE (VALUE-BASED)
7 DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 
    7.1 INTRODUCTION 
    7.2 MHEALTH 
           7.2.1 MHEALTH DEVICES
                    7.2.1.1 VITAL SIGN MONITORS
                    7.2.1.2 PEAK FLOW METERS
                    7.2.1.3 FETAL MONITORS
                    7.2.1.4 SLEEP APNEA MONITORS
                    7.2.1.5 NEUROLOGICAL MONITORS
                    7.2.1.6 OTHERS
           7.2.2 MHEALTH APPS
                    7.2.2.1 MEDICAL APPS
                    7.2.2.2 FITNESS APPS
    7.3 TELEHEALTHCARE 
           7.3.1 TELECARE
                    7.3.1.1 ACTIVITY MONITORING
                    7.3.1.2 REMOTE MEDICATION MANAGEMENT
           7.3.2 TELEHEALTH 
                    7.3.2.1 LTC MONITORING
                    7.3.2.2 VIDEO CONSULTATION
    7.4 DIGITAL THERAPEUTICS 
           7.4.1 PREVENTIVE APPLICATIONS
           7.4.2 TREATMENT APPLICATIONS
    7.5 HEALTH MANAGEMENT SOLUTIONS 
           7.5.1 EHR
           7.5.2 HEALTHCARE ANALYTICS
           7.5.3 E-PRESCRIBING
8 DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 
    8.1 INTRODUCTION 
    8.2 CHRONIC DISEASE MANAGEMENT 
    8.3 BEHAVIOURAL HEALTH 
    8.4 HEALTH & FITNESS 
    8.5 OTHERS 

9 DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 
    9.1 INTRODUCTION 
    9.2 PROVIDERS 
           9.2.1 HOSPITALS & CLINICS
           9.2.3 LONG TERM CARE CENTERS & ASSISTED LIVING CENTERS
    9.3 PAYERS 
           9.3.1 PUBLIC
           9.3.2 PRIVATE 
    9.4 PATIENTS & CONSUMERS 
10 DIGITAL HEALTH MARKET, BY REGION, 2021–2028 (USD MILLION) 
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 RECESSION IMPACT
             10.2.2 US
             10.2.3 CANADA
     10.3 EUROPE 
             10.3.1 RECESSION IMPACT
             10.3.2 GERMANY
             10.3.3 UK
             10.3.4 FRANCE
             10.3.5 REST OF EUROPE
     10.4 ASIA PACIFIC 
             10.4.1 RECESSION IMPACT
             10.4.2 JAPAN
             10.4.3 CHINA
             10.4.4 INDIA
             10.4.5 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA 
             10.5.1 RECESSION IMPACT
     10.6 MIDDLE EAST AND AFRICA 
             10.6.1 RECESSION IMPACT
11 COMPETITIVE LANDSCAPE 
     11.1 INTRODUCTION 
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
     11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 
     11.4 MARKET SHARE/RANKING ANALYSIS 
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
             11.5.5 COMPANY FOOTPRINT
     11.6 START-UP/SME EVALUATION MATRIX 
             11.5.1 PROGRESSIVE COMPANIES
             11.5.2 RESPONSIVE COMPANIES
             11.5.3 DYNAMIC COMPANIES 
             11.5.4 STARTING BLOCKS
             11.5.5 COMPETITIVE BENCHMARKING
     11.7 COMPETITIVE SCENARIOS AND TRENDS 
             11.5.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
             11.5.2 DEALS
             11.5.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES 
     12.1 KEY COMPANIES 
             12.1.1 KONINKLIJKE PHILIPS N.V.
             12.1.2 MEDTRONIC
             12.1.3 GE HEALTHCARE
             12.1.4 ABBOTT
             12.1.5 OMRON CORPORATION
             12.1.6 JOHNSON & JOHNSON PRIVATE LIMITED
             12.1.7 MASIMO
             12.1.8 MERATIVE
             12.1.9 FITBIT, INC. (A GOOGLE COMPANY)
             12.1.10 AT & T, INC.
             12.1.11 NOOM, INC.
             12.1.12 TELADOC HEALTH, INC.
             12.1.13 OMADA HEALTH INC.
             12.1.14 DEXCOM
             12.1.15 SIEMENS HEALTHINEERS
             12.1.16 APPLE, INC.
             12.1.17 BIOTRICITY
             12.1.18 VERADIGM LLC
     12.2 OTHER PLAYERS 
             12.2.1 IHEALTH LABS, INC.
             12.2.2 MY MHEALTH LIMITED
             12.2.3 ATHENAHEALTH, INC.
             12.2.4 ECLINICALWORKS
             12.2.5 AIRSTRIP TECHNOLOGIES, INC
             12.2.6 ADVANCEDMD, INC.
             12.2.7 QARDIO, INC.
13 APPENDIX 
     13.1 INSIGHTS OF INDUSTRY EXPERTS 
     13.2 DISCUSSION GUIDE 
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.4 CUSTOMIZATION OPTIONS 
     13.5 RELATED REPORTS 
     13.6 AUTHOR DETAILS